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Abstract
Background: Dietary iron intake is associated with bone metabolism in human and animals. Previous studies have
suggested that iron deficiency diminishes bone formation and causes bone loss in rats, however, the detailed
mechanisms remain unclear. To clarify the mechanism of the diminishing bone formation in iron deficiency, we
examined the renal 25-hydroxyvitamin D3-1α-hydroxylase (1α-hydroxylase) activity and femoral expression of bone
formation-related genes in iron-deficient rats.
Methods: Male Wistar rats (n = 18) at 3 weeks of age were divided into three groups of six rats each. Two groups
of rats were given free access to a control diet or an iron-deficient diet for 4 weeks. Rats in the third group were
pair-fed the control diet, calculated as the mean food intake of the iron-deficient group.
Results: Following the treatment, compared with the control and pair-fed groups, hemoglobin and liver iron
concentrations were significantly lower and heart weight was significantly higher in the iron-deficient group.
Serum 1,25-dihydroxyvitamin D3 concentration and renal 1α-hydroxylase activity were significantly lower in the
iron-deficient group compared with the control and pair-fed groups. Serum osteocalcin concentration and bone
mineral density of the femur were also significantly lower in the iron-deficient group compared with the control
and pair-fed groups. Furthermore, iron-deficient diet decreased runt-related transcription factor 2, osteocalcin,
and type I collagen mRNA expression in the femur.
Conclusions: Our findings indicate that iron deficiency reduces renal 1α-hydroxylase activity, leading to a decreased
bone formation in rats.
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Background
Iron deficiency anemia is an important health problem
throughout the world, and several researchers have
studied the relationships between dietary iron and bone
metabolism in human and animals. In human studies,
iron intake was positively associated with bone mineral
density (BMD) in postmenopausal women [1, 2]. In rats,
bone mineral content (BMC), BMD, and bone strength
were reduced in the iron-deficient rats [3, 4]. Therefore,
it was concluded that iron deficiency affects not only
anemia but also bone metabolism.
Parelman et al. [5] reported that the mineralization of
hFOB 1.19 cells treated with deferoxamine, iron-chelating
agent, in vitro was decreased [5], while Messer et al.
demonstrated that the chronic deferoxamine treatment
suppressed osteoblast phenotype development in primary
rat calvaria-derived osteoblasts during differentiation [6].
Our previous study showed that iron deficiency decreases
BMC, BMD, and bone strength in rats, together with
diminishing bone formation [7]. Additionally, we demon-
strated that iron deficiency diminishes bone formation rate,
which was reflected in a decreased serum 1,25-dihydroxy-
vitamin D3 concentration in the iron-deficient rats [8].
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Therefore, iron deficiency-induced bone loss may be due
to the diminished bone formation, though the detailed
mechanisms remain unclear. Furthermore, the influence of
iron deficiency on the bone formation-related mRNA ex-
pression levels in rats have not been investigated.
Iron is a key factor of the enzymes related to bone me-
tabolism. Prolyl and lysyl hydroxylases, which contain
iron as a cofactor, play important roles in collagen syn-
thesis [9]. Also, renal 25-hydroxyvitamin D3-1α-hydroxy-
lase (1α-hydroxylase) converts 25-hydroxyvitamin D to
1,25-dihydroxyvitamin D, the active form of vitamin D,
and contains iron as a cofactor [10]. Therefore, as a
consequence of iron deficiency, these iron-containing en-
zymes activity may be lowered, and hence metabolic dis-
order of collagen and vitamin D may occur. In previous
studies, researchers hypothesized that abnormal me-
tabolism of collagen and vitamin D might cause bone
loss in iron deficiency; however, the detailed mecha-
nisms remain unclear.
The purpose of this study was to clarify the effects of
iron deficiency on vitamin D metabolism and bone for-
mation in rats. We investigated renal 1α-hydroxylase ac-
tivity and bone formation-related mRNA expression
levels of the femur in rats fed an iron-deficient diet.
Methods
Experimental design
The experimental design has been previously described
[8]. Briefly, male Wistar rats (Clea Japan, Tokyo, Japan)
at 3 weeks of age were individually housed in stainless-
steel wire-mesh cages and kept under a 12-hour light–dark
cycle in a room maintained at 22 °C. Before the study
period began, rats were given free access to a control diet
for a 3 days. Afterward, rats were randomly divided into
three groups of six rats each. Two groups of rats were
given free access to the control diet or an iron-deficient
diet. Rats in the third group were pair-fed the control diet
at the same level of food intake as the iron-deficient group.
The control and iron-deficient diets were prepared accord-
ing to the composition of the AIN-93G diet (Additional
file 1: Table S1) [11]. The rats were fed their respective
diets and were given free access to deinonized water for
4 weeks. Metabolic cages allowed the urine collection
from the experimental animals for 24 h, immediately
before sacrifice. For bone histomorphometry, rats were
subcutaneously injected with tetracycline hydrochloride
(20 mg/kg body weight) and calcein (20 mg/kg body
weight) at 5 days and 2 days prior to sacrifice, respectively.
On the last day of the experimental period, rats were
sacrificed under anesthesia, and blood samples and tissues
were collected. Hemoglobin concentration was measured
using a part of the blood sample (Hemoglobin B-test
Wako, Wako Pure Chemical Industries, Osaka, Japan).
Serum and urine analyses
Serum 1,25-dihydroxyvitamin D3 concentration was mea-
sured using 1,25(OH)2 vitamin D ELISA kit (Immundiag-
nostik AG, Bensheim, Germany). Serum osteocalcin (OC)
was measured with Rat Osteocalcin (BGP) ELISA system
(GE Healthcare Japan Corporation, Tokyo, Japan). Urinary
deoxypyridinoline (DPD) was measured using METRA
DPD EIA kit (Quidel, CA, USA), while urinary creatinine
was measured by the Jaffe reaction, as previously reported
by Lustgarten and Wenk [12]. Urinary DPD was normal-
ized with respect to the urinary creatinine concentration.
Liver and kidney iron concentration measurements
After the sacrifice, livers were perfused with ice-cold
0.9 % NaCl solution via their portal veins until the blood
color of the livers disappeared. In order to measure iron
concentrations in liver and kidney, these samples were
dried, ashed, and afterward demineralized with a 1 mol/l
HCl solution. Iron was analyzed by atomic absorption
spectrophotometry (A-2000; Hitachi, Ltd., Tokyo, Japan).
Renal 1α-hydroxylase activity
Renal 1α-hydroxylase activity was measured using the
modified Vieth et al. [13] and Ishida et al. [14] methods.
Right kidney was homogenized in 10 volumes of ice-cold
homogenization buffer (250 mmol/l sucrose, 10 mmol/l
HEPES, and 10 mmol/l KCl, pH 7.4). The homogenate
was centrifuged at 4000 × g at 4 °C for 40 s, and the super-
natant was centrifuged at 9000 × g at 4 °C for 20 min. The
pellet, which consisted mainly of mitochondria, was resus-
pended in 10 volumes of ice-cold incubation buffer
(125 mmol/l KCl, 20 mmol/l HEPES, and 2 mmol/l
MgCl2, pH 7.4), and the protein concentration was mea-
sured with Protein Assay Rapid kit (Wako Pure Chemical
Industries). The final mitochondrial protein concentration
was 3–4 mg/ml. Each tube contained 1.98 ml of mito-
chondrial suspension and it was pre-incubated at 37 °C
for 3 min. Afterward, the reaction was initiated by adding
25 nmol 25-hydroxyvitamin D3 in 0.02 ml of ethanol. The
samples were incubated additionally for 10 min, and re-
action was stopped by the addition of 0.2 ml 10 %
trichloroacetic acid. The 1,25-dihydroxyvitamin D3 concen-
tration in the final solutions was measured using 1,25(OH)2
vitamin D ELISA kit (Immundiagnostik AG). Renal lα-
hydroxylase activity was expressed as the level of 1,25-dihy-
droxyvitamin D3 generated from 25-hydroxyvitamin D3.
Measurements of BMC, area, and BMD of the femur
BMC, area, and BMD of the left femur were measured
using the dual-energy X-ray absorptiometry (DEXA;
DCS-600EX, Aloka, Tokyo, Japan). BMD was calculated
by the BMC of the measured area.
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Bone histomorphometry
Bone histomorphometry was performed as described pre-
viously [8]. Briefly, the undecalcified second lumbar verte-
bra were embedded in methyl methacrylate and 5 μm
sections were obtained using a microtome. The bone his-
tomorphometry was performed using a semiautomatic
image analyzing system (System Supply, Nagano, Japan)
and a fluorescent microscope (Optiphot; Nikon, Tokyo,
Japan). The area occupied by the trabecular bone was
measured on each section. Standard bone histomorpho-
metrical nomenclatures, symbols, and units were used in
this study as described in the report of the American
Society for Bone and Mineral Research [15].
Isolation of total RNA and real-time PCR
For the extraction of total RNA, the right femur was
homogenized using TRIzol reagent (Life Technologies,
CA, USA), and total RNA was isolated from the lysate
according to the manufacturer’s instructions. The amount
and purity of the RNA were assessed using NanoDrop
2000c (Thermo Fisher Scientific, MA, USA). cDNA was
synthesized using the High-Capacity RNA-to-cDNA Kit
(Applied Biosystems, CA, USA). Real-time PCR was car-
ried out with the TaqMan Gene Expression Master Mix
(Applied Biosystems) and TaqMan gene expression assays
(Applied Biosystems) for rat runt-related transcription fac-
tor 2 (Runx2) (Assay ID: Rn01512298_m1), rat Osterix
(Assay ID: Rn02769744_s1), rat alkaline phosphatase
(ALP) (Assay ID: Rn01516028_m1), rat OC (Assay ID:
Rn00566386_g1), rat type I collagen (Col1a1) (Assay ID:
Rn01463848_m1), and rat β-actin (Assay ID: Rn0066
7869_m1). Real-time PCR reaction was performed using a
StepOne Real-Time PCR System (Applied Biosystems),
and mRNA expression levels were normalized to β-actin
mRNA levels. The value of control group was considered
to be 1.00.
Statistical analysis
Results are expressed as the mean ± SE for each group of
6 rats. Following one-way analysis of variance (ANOVA),
Fisher’s PLSD test was used to analyze statistically sig-
nificant differences between the groups. Differences were
considered significant when p value was less than 0.05.
Results
Body weight, food intake, and iron deficiency indicators
As previously reported [8], we have shown that final
body weight and food intake were significantly lower in
the iron-deficient and pair-fed groups compared with
the control group, and there were no significant differences
in these parameters between the iron-deficient and pair-fed
groups (Additional file 1: Table S2). Also, we have
showed that iron-deficient diet caused severe anemia,
which resulted in a greater decrease in hemoglobin and
liver iron concentrations, and in an increase in heart
weight.
Bone turnover markers and BMC, area, and BMD of the
femur
Similar to our previous study [8], iron deficiency decreased
bone formation and resorption, from the results of bone
turnover markers (Additional file 1: Table S3). Also, iron-
deficient diet decreased BMC, area, and BMD of the femur.
Serum 1,25-dihydroxyvitamin D3 concentration, renal iron
concentration, and renal 1α-hydroxylase activity
Serum 1,25-dihydroxyvitamin D3 concentration was sig-
nificantly lower in the iron-deficient group in compari-
son with the control and pair-fed groups, and there was
no significant difference in the concentration levels between
the control and pair-fed groups (Fig. 1). Renal iron concen-
tration and 1α-hydroxylase activity were significantly lower
in the iron-deficient group compared with the control and
Fig. 1 Serum 1,25-dihydroxyvitamin D3 concentration (a), renal iron concentration (b), and 1α-hydroxylase activity (c) of the control (C),
iron-deficient (ID), and pair-fed (PF) groups. The data are presented as the mean ± SE for each group of 6 rats. a,bThe different letters denote
significant differences (p < 0.05)
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pair-fed groups, and there were no significant differences in
these factors between the control and pair-fed groups.
Bone histomorphometry
Bone volume (BV/TV) and mineral apposition rate (MAR)
did not differ between the groups (Fig. 2). Mineralizing sur-
face (MS/BS) was significantly lower in the iron-deficient
group in comparison with the control and pair-fed groups,
and there was no significant difference between the control
and pair-fed groups. Compared with the pair-fed group,
bone formation rate (BFR/BS) was significantly lower in the
iron-deficient group. Osteoblast surface (Ob.S/BS) was sig-
nificantly lower in the iron-deficient group than in the con-
trol group. Osteoclast surface (Oc.S/BS) was significantly
lower in the iron-deficient group compared with the
pair-fed group. Osteoclast number (N.Oc/BS) tended to
be lower in the iron-deficient group compared with the
control (p = 0.05) and pair-fed (p = 0.08) groups.
The expression of the bone formation-related genes in
the femur
The expression of Runx2 and OC was demonstrated to
be significantly decreased in the iron-deficient group
compared with the control and pair-fed groups (Fig. 3).
Osterix and ALP mRNA levels were significantly de-
creased in the iron-deficient and pair-fed groups com-
pared with the control group. Col1a1 mRNA expression
was significantly lower in the iron-deficient and pair-fed
groups compared with the control group, and tended to
be lower in the iron-deficient group compared with the
pair-fed group (p = 0.06).
Discussion
Our previous studies showed that iron-deficient diet causes
a decline in bone formation in rats [7, 8]. Additionally,
iron-deficient diet decreased the concentration of serum N-
terminal propeptide of type I collagen, which is one of the
sensitive bone formation marker in rats [16]. An in vitro
study demonstrated that the chronic deferoxamine treat-
ment suppressed bone sialoprotein, ALP, and OC mRNA
expression in primary rat calvaria-derived osteoblasts dur-
ing differentiation [6]. These results support the hypothesis
that iron deficiency results in adverse effects on osteoblastic
bone formation, which can cause bone loss. In this study,
serum OC concentrations were determined to be signifi-
cantly lower in the iron-deficient group compared with the
control and pair-fed groups. Furthermore, bone histo-
morphometric parameters indicated a decrease in bone
formation in rats fed the iron-deficient diet. MS/BS was
significantly lower in the iron-deficient group in compari-
son with the control and pair-fed groups, BFR/BS was sig-
nificantly lower in the iron-deficient group compared with
the pair-fed group, and Ob.S/BS was significantly lower in
the iron-deficient group in comparison with the control
group. These results suggest that iron deficiency leads to
reduced bone formation, which can cause a decline in
BMC and BMD in this study, as previously reported [8].
Iron deficiency was related to vitamin D status in
humans, and it was known as one of the risk factors for
vitamin D deficiency [17]. However, Díaz-Castro et al. re-
ported that no significant difference was observed in circu-
lating 25-hydroxyvitamin D3 concentrations between
normal rats and iron-deficient rats [16]. The active form of
vitamin D is 1,25-dihydroxyvitamin D3, and in this study,
we showed that serum 1,25-dihydroxyvitamin D3 concen-
trations were significantly lower in the iron-deficient group
than in the control and pair-fed groups. This may suggest
that iron deficiency resulted in a mild vitamin D deficiency,
and these results agree with the results obtained in our
previous study [8]. Dietary vitamin D restriction decreased
the linear rate of bone mineral apposition in rats [18], and
vitamin D receptor knockout mice showed a decrease in
bone formation rate [19]. Thus, a lower serum 1,25-dihy-
droxyvitamin D3 concentration caused by iron deficiency
may have led to a decrease in BFR/BS and Ob.S/BS ob-
served in this study.
The conversion from 25-hydroxyvitamin D3 to 1,25-
dihydroxyvitamin D3 requires hydroxylation by 1α-
hydroxylase in the kidneys. Renal 1α-hydroxylase is
located in mitochondria, and contains iron as a cofactor
[10]. We speculated that iron deficiency may influence
the activity of this enzyme, and consequently, a decline
in 1,25-dihydroxyvitamin D3 may cause a decrease in
BMC and BMD. Here, renal iron concentration and 1α-
hydroxylase activity were significantly lower in the
iron-deficient group in comparison with the control
and pair-fed groups. These results indicate that iron defi-
ciency decreases renal iron concentration, which further
diminishes 1α-hydroxylase activity, leading to a decrease
in serum 1,25-dihydroxyvitamin D3 concentration.
During the osteoblast differentiation, Runx2 and Osterix
act as essential transcription factors [20, 21], and here we
showed that Runx2 mRNA level was significantly de-
creased in the iron-deficient group compared with the
control and pair-fed groups, while Osterix mRNA was sig-
nificantly lower in the iron-deficient group in comparison
with the control group. These results indicate that iron
deficiency diminishes Runx2 and Osterix expression,
which results in Ob.S/BS decrease. Furthermore, Runx2
regulates the several osteoblastic genes expression, includ-
ing osteopontin, bone sialoprotein, OC, and Col1a1 [22].
We observed that iron deficiency induces downregulation
of OC and Col1a1. We previously showed that iron defi-
ciency might cause abnormal collagen synthesis in rats,
resulting from a decrease in hydroxyproline content of the
femur [23]. We report here that Col1a1 mRNA expression
levels were lower in the iron-deficient group compared
with the control group. Downregulation of Col1a1 could
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be a result of hydroxyproline content decrease observed
in the previous study.
Urinary DPD excretion was significantly lower in the
iron-deficient group compared with the control and
pair-fed groups, Oc.S/BS was significantly lower in the
iron-deficient group compared with the pair-fed group,
and N.Oc/BS tended to be lower in the iron-deficient
group than in the control and pair-fed groups. These re-
sults indicate that iron deficiency causes a decrease in
bone resorption, which is consistent with the results of
Fig. 2 Bone histomorphometric parameters of the lumbar vertebra of the control (C), iron-deficient (ID), and pair-fed (PF) groups. a BV/TV; b MS/BS;
c MAR; d BFR/BS; e Ob.S/BS; f Oc.S/BS; g N.Oc/BS. The data are presented as the mean ± SE for each group of 6 rats. a,bThe different letters denote
significant differences (p < 0.05)
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our previous study [8]. However, Díaz-Castro et al.
reported that iron deficiency increases the serum con-
centrations of tartrate-resistant acid phosphatase and C-
terminal telopeptides of type I collagen in rats [16],
which leads to the opposite conclusions about the influ-
ence of iron deficiency on bone resorption process.
Díaz-Castro et al. reported that hemoglobin concentra-
tion of the iron-deficient rats was decreased to ~60 %
compared with the control rats. In contrast, this study
showed that the hemoglobin concentrations of the iron-
deficient group were greatly decreased to ~26 % com-
pared with the control group and to ~24 % compared
with the pair-fed group. These results showed that the
degree of iron deficiency anemia might have been more
severe in the iron-deficient rats of this study than in
those of the study of Díaz-Castro et al. [16]. Therefore,
we suggest that the differences in bone resorption between
our study and the study of Díaz-Castro et al. [16] were
caused by the different degrees of anemia, but detailed
studies are needed in the future, in order to clarify bone
resorption mechanisms resulting from the iron deficiency.
Iron deficiency anemia as severe as in the iron-
deficient rats of this study is perhaps rare in human sub-
jects. However, iron deficiency has been one of the risk
factors for impaired vitamin D metabolism in humans
[17]. Therefore, even in humans, continuous lower iron
intake and/or severe iron deficiency may affect vitamin
D metabolism, resulting in substantial bone loss. Iron
deficiency is an important worldwide health problem
and bone disorders such as osteoporosis and osteopenia
are also highly prevalent. Thus, our findings might be
expected to provide further beneficial information for
prevention of bone disorders.
Conclusions
We examined the effects of iron-deficient diet on renal
1α-hydroxylase activity and femoral mRNA expression
of bone formation-related genes in rats. Decrease in
renal 1α-hydroxylase activity caused a decline in serum
1,25-dihydroxyvitamin D3 levels, which diminished bone
formation in iron-deficient rats. Furthermore, iron
deficiency-induced downregulation of Runx2 and Oste-
rix may influence osteoblast differentiation.
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